K M C Speciality Hospitals (India) profitability ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY24Mar 2024FY23Mar 2023FY22Mar 2022FY21Mar 2021FY20 and earlierAlpha Plus
Returns
FY20 and earlierEvery year the company has filed comes with Alpha Plus.
—26.7%31.6%34.6%
—17.2%20.3%14.6%
—21.2%——
—16.5%——
Margins
26.8%26.5%27.3%22.6%
21.5%21.6%22.5%16.6%
21.0%15.4%40.6%—
22.9%23.1%23.6%17.6%
17.2%17.1%17.4%12.5%
21.7%—21.4%24.9%
Additional
25.1%25.9%26.1%29.2%
—26.7%31.6%34.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KMCSHIL₹149.36

K M C Speciality Hospitals (India) Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDMcap ₹2,439 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY21
31/03/2021
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Returns
Return on Common Equity34.5531.6126.65—
Return on Assets14.6120.3017.20—
Return on Capital Employed——21.16—
Return on Invested Capital——16.48—
Margins
EBITDA Margin22.6427.3226.5326.75
Operating Margin16.6322.5221.6221.54
Incremental Operating Margin—40.6115.3720.96
Pretax Margin17.5823.5923.1122.89
Net Income Margin12.4517.4417.1317.15
FCF Margin24.9421.40—21.68
Additional
Effective Tax Rate29.1826.0825.8525.10
Sustainable Growth Rate34.5531.6126.65—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.